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It is well known that steroids play an important role in biolog-
ical processes and thus have the potential to be developed as
drugs for the treatment of a large number of diseases including
cardiovascular (Dubey et al., 2002), autoimmune diseases
(Latham et al., 2003), etc. 16-Dehydropregnenolone acetate
(16-DPA, 3b-(acetyloxy)pregna-5,16-dien-20-one), a steroidal
intermediate, is well prepared from diosgenin or from solaso-
dine (Chowdhury et al., 1998, 2011; Goswami et al., 2003;
Micovic et al., 1990; Vronena et al., 2004). There have been
various reports on structural diversity and biological activities
of steroids from 16-DPA (Banerjee et al., 2003; Hartmann
et al., 2000; Kumar et al., 2011; Njar et al., 1998), includingpreparation of adrenocorticoids drugs, glucocorticoid drugs,
steroidal anti-inﬂammatory drugs, sexual hormones, and so
on. About preparation of steroidal derivatives, introduction
of a methyl group at a certain position of steroids may signif-
icantly change their bioactivities (Li et al., 2010). For example,
introduction of methyl group at C-7 position of steroids
affords important biological active compounds, such as tibo-
lone (therapeutic against tumors, cardiovascular disorders)
(Zheng and Li, 2003). Therefore, the investigation of new mod-
iﬁed steroid derivatives condensed with various groups or rings
has been given great attention. For instance, Khan and Asiri
(2011) have recently synthesized series of novel steroidal oxaz-
olo quinoxaline derivatives by the multi-step reactions of
steroid, and found their antibacterial activity. In our search
for various physiologically important steroid derivatives,
7-O-methylation metabolites from Penicillium citrinum were
obtained by microbial transformations using 16-DPA as the
substrate (Gao et al., 2011), and some polyhydroxylated ste-
roids from Ginkgo biloba were also isolated (Qin et al., 2009).
In view of the therapeutic importance of steroids, our pres-
ent study is focusing on the synthesis and cytotoxic evaluation
of a new series of substituted steroids containing modiﬁcationsf Chem-
2 J.-J. Tang et al.at C-20 position. The new compounds were obtained by chem-
ical modiﬁcations to the structure of the commercially avail-
able substrate, 16-dehydropregnenolone acetate (16-DPA). In
the course of chemical modiﬁcations, condensation of 16-
DPA and hydroxylamine gave a key intermediate, 3b-acet-
oxy-5,16-pregnadien-20-oxime 2, followed by acylation of 2
with appropriate acid chlorides to afford a series of C-20
oxime ester derivatives 3a-w (Scheme 1). Their cytotoxicity
activities against human cancer cell lines, acute promyelocytic
leukemia cells (NB4), prostate carcinoma cells (PC-3) and cer-
vix adenocarcinoma cells (HeLa) were tested. Herein, we
report the synthesis and preliminary cytotoxic activities of
novel steroidal C-20 oxime ester derivatives.
2. Material and methods
2.1. Material
Melting points were obtained on an XRC-1 apparatus (Beijing
Tech Instrument Co., China) and uncorrected. Infrared (IR)
spectra were measured with a Bruker Tensor 27 spectropho-
tometer (BrukerOptics, Germany) in KBr pellets. Nuclear
magnetic resonance (NMR) spectra were recorded on a Bruker
Avance III spectrometer (Unity Plus 500 MHz) (Bruker Bio-
Spin, Rheinstetten, Germany) with TMS as internal standard.
Electrospray ionization mass spectrometry (ESI-MS) data
were obtained on a Thermo Fisher LTQ Fleet instrument spec-
trometer (Thermo Scientiﬁc, USA). Thin-layer chromatogra-
phy (TLC) was performed on silica gel 60 F254 (Qingdao
Marine Chemical Ltd., China). Column chromatography
(CC) was performed over silica gel (200–300 mesh, Qingdao
Marine Chemical Ltd.). 16-Dehydropregnenolone acetate
(16-DPA, purity > 99%) was obtained from Hunan Keyuan
Biological Products Co., Ltd. All acid chloride, trypan blue
and etoposide were purchased from Sigma–Aldrich. RPMI
medium 1640 was from GIBCO. All other chemicals used in
this study without stated are of analytical grade.
2.2. Preparation of compounds 3a-w
The steroidal C-20 oxime (2) was synthesized according to the
method (Micovic et al., 1990). Firstly, acidic hydroxylamine
(NH2OHÆHCl, 0.1 mol) was added dropwise to a stirred solu-
tion of 16-DPA (7.13 g, 0.02 mol) in 95%EtOH (150 mL) and
pyridine (8 mL, 0.1 mol) at room temperature. The resulting
mixture was reﬂuxed for 0.5 h, and cooled in cold water for
1 h. The precipitate was collected by suction, washed withScheme 1 Reagents and conditions: (a) NH2OHÆHCl, 95%
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product steroidal C-20 oxime (2) was obtained with 95% yield
(6.90 g). Secondly, to a solution of 2 (74.3 mg, 0.2 mmol), tri-
ethylamine (Et3N, 0.1 mL) in dichloromethane (CH2Cl2,
30 mL) was added appropriate acid chloride (0.2 mmol)),
and stirred for 0.5 h at room temperature. Then, resulting mix-
ture was directly concentrated in vacuum, and the residue was
puriﬁed by chromatography on silica gel (chloroform /acetone)
to afford the desired oxime ester derivatives (3a-w) as white
solids with above 85% yield.
2.2.1. 3b-(Acetyloxy)pregna-5,16-dien-20-one O-(2-
ﬂuorobenzoyl) oxime (3a): mp. 151–153 C
IR: 2900, 1727, 1455, 1285, 1237, 1109, 1083, 1031, 913, 811,
760 cm1.
1
HNMR (500 MHz, CDCl3), d (ppm): 1.08(s, 3H,
18-CH3), 1.09(s, 3H, 19-CH3), 2.07(s, 3H, –OAc), 2.23(s, 3H,
21-CH3), 4.61(m, 1H, 3a-H), 5.41(d, 1H, 6-H, J= 5.20),
6.38(brd, 1H, 16-H, J= 2.00), 7.18(td, 1H, ph-H, J= 1.60,
8.75), 7.26(td, 1H, ph-H, J= 0.70, 7.50), 7.58(m, 1H, ph-H),
8.03(td, 1H, ph-H, J= 1.75, 7.45).
13
CNMR (125 MHz,
CDCl3), d (ppm): 170.52, 160.49, 150.98, 140.32, 137.73,
134.60, 134.52, 132.39, 124.19, 124.16, 122.10, 117.05, 116.87,
73.95, 56.94, 50.39, 46.97, 38.17, 36.87, 36.81, 35.32, 32.16,
31.58, 30.31, 27.75, 21.43, 20.86, 19.21, 15.81, 13.74. ESI-MS
m/z [M+Na]+: 515.94.
2.2.2. 3b-(Acetyloxy)pregna-5,16-dien-20-one O-(3-
ﬂuorobenzoyl) oxime (3b): mp. 171–172 C
IR: 2900, 1741, 1265, 1237, 1181, 1054, 1032, 898, 801, 748,
674 cm1.
1
HNMR (500 MHz, CDCl3), d (ppm): 1.08(s, 3H,
18-CH3), 1.09(s, 3H, 19-CH3), 2.08(s, 3H, –OAc), 2.24(s, 3H,
21-CH3), 4.61(m, 1H, 3a-H), 5.41(d, 1H, 6-H, J= 5.20),
6.38(brd, 1H, 16-H, J= 2.00), 7.30(td, 1H, ph-H, J= 2.10,
8.15), 7.47(m, 1H, ph-H), 7.76(brd, 1H, ph-H, J= 8.50),
7.89(d, 1H, ph-H, J= 7.75).
13
CNMR (125 MHz, CDCl3), d
(ppm): 170.53, 160.53, 150.94, 140.32, 137.90, 130.23, 130.16,
125.30, 125.27, 122.08, 120.27, 120.10, 116.40, 73.94, 56.94,
50.38, 46.99, 38.17, 36.87, 36.81, 35.32, 32.17, 31.57, 30.31,
27.75, 21.43, 20.86, 19.21, 15.81, 13.50. ESI-MS m/z
[M+Na]+: 515.97.
2.2.3. 3b-(Acetyloxy)pregna-5,16-dien-20-one O-(2,4-
diﬂuorobenzoyl) oxime (3c): mp. 172–174 C
IR: 2900, 1730, 1621, 1247, 1113, 1033, 971, 907, 831, 761, 677,
612 cm1.
1
HNMR (500 MHz, CDCl3), d (ppm): 1.07(s, 3H,
18-CH3), 1.09(s, 3H, 19-CH3), 2.08(s, 3H, –OAc), 2.22(s, 3H,
21-CH3), 4.61(m, 1H, 3a-H), 5.41(d, 1H, 6-H, J= 5.20),EtOH, pyridine, 100 C; (b) R-COCl, CH2Cl2, Et3N, rt.
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ph-H), 8.08(m, 1H, ph-H).
13
CNMR (125 MHz, CDCl3), d
(ppm): 170.53, 160.58, 150.89, 140.31, 137.92, 134.26, 134.18,
122.08, 112.19, 111.49, 105.45, 105.24, 105.03, 73.94, 56.94,
50.38, 46.97, 38.17, 36.87, 36.81, 35.32, 32.17, 31.57, 30.31,
27.75, 21.43, 20.86, 19.21, 15.80, 13.75. ESI-MS m/z
[M+Na]+: 533.95.
2.2.4. 3b-(Acetyloxy)pregna-5,16-dien-20-one O-(3,4-
diﬂuorobenzoyl) oxime (3d): mp. 168–170 C
IR: 2900, 1740, 1724, 1515, 1296, 1245, 1180, 1062, 1033, 900,
838, 774, 753, 638 cm1.
1
HNMR (500 MHz, CDCl3), d (ppm):
1.07(s, 3H, 18-CH3), 1.09(s, 3H, 19-CH3), 2.06(s, 3H, –OAc),
2.23(s, 3H, 21-CH3), 4.64(m, 1H, 3a-H), 5.42(d, 1H, 6-H,
J= 5.20), 6.39(brd, 1H, 16-H, J= 2.00), 7.28(q, 1H, ph-H,
J= 8.73), 7.88(m, 1H, ph-H), 7.90(m, 1H, ph-H).
13
CNMR
(125 MHz, CDCl3), d (ppm): 170.53, 160.61, 151.14, 150.86,
140.32, 138.08, 126.54, 122.06, 118.92, 118.77, 117.66, 117.52,
73.93, 56.94, 50.38, 46.99, 38.17, 36.87, 36.81, 35.32, 32.18,
31.56, 30.30, 27.75, 21.42, 20.86, 19.21, 15.80, 13.50. ESI-MS
m/z [M+Na]+: 533.91.
2.2.5. 3b-(Acetyloxy)pregna-5,16-dien-20-one O-(3,5-
diﬂuorobenzoyl) oxime (3e): mp. 183–185 C
IR: 2900, 1754, 1729, 1324, 1248, 1193, 1124, 1084, 1033, 991,
958, 899, 864, 757, 665 cm1.
1
HNMR (500 MHz, CDCl3), d
(ppm): 1.07(s, 3H, 18-CH3), 1.09(s, 3H, 19-CH3), 2.06(s, 3H,
–OAc), 2.24(s, 3H, 21-CH3), 4.64(m, 1H, 3a-H), 5.42(d, 1H,
6-H, J= 5.20), 6.40(brd, 1H, 16-H, J= 2.00), 7.06(s, 1H,
ph-H), 7.59(s, 1H, ph-H), 7.60(s, 1H, ph-H).
13
CNMR
(125 MHz, CDCl3), d (ppm): 170.52, 160.85, 150.78, 140.32,
138.31, 132.77, 122.06, 112.66, 112.61, 112.50, 112.45, 108.57,
108.37, 73.93, 56.93, 50.38, 46.99, 38.17, 36.87, 36.81, 35.30,
32.20, 31.56, 30.30, 27.75, 21.42, 20.86, 19.21, 15.79, 13.54.
ESI-MS m/z [M+Na]+: 533.90.
2.2.6. 3b-(Acetyloxy)pregna-5,16-dien-20-one O-(2-
chlorobenzoyl) oxime (3f): mp. 150–151 C
IR: 2900, 1735, 1242, 1100, 906, 745, 648 cm1.
1
HNMR
(500 MHz, CDCl3), d (ppm): 1.08(s, 3H, 18-CH3), 1.09(s,
3H, 19-CH3), 2.05(s, 3H, –OAc), 2.21(s, 3H, 21-CH3),
4.61(m, 1H, 3a-H), 5.41(d, 1H, 6-H, J= 5.20), 6.36(brd, 1H,
16-H, J= 2.00), 7.36(td, 1H, ph-H, J= 1.20, 7.70), 7.48(m,
1H, ph-H), 7.49(m, 1H, ph-H), 7.85(dd, 1H, ph-H, J= 1.40,
7.75).
13
CNMR (125 MHz, CDCl3), d (ppm): 170.53, 163.66,
160.33, 150.90, 140.31, 137.84, 133.38, 132.43, 131.29, 130.91,
130.11, 126.65, 122.09, 73.94, 56.93, 50.37, 46.93, 38.17,
36.87, 36.80, 35.24, 32.15, 31.57, 30.30, 27.75, 21.43, 20.81,
19.21, 15.77, 13.85. ESI-MS m/z [M+Na]+: 531.87.
2.2.7. 3b-(Acetyloxy)pregna-5,16-dien-20-one O-(3-
chlorobenzoyl) oxime (3g): mp. 166–168 C
IR: 2900, 1752, 1729, 1284, 1234, 1062, 1030, 919, 864,
741 cm1.
1
HNMR (500 MHz, CDCl3), d (ppm): 1.08(s, 3H,
18-CH3), 1.09(s, 3H, 19-CH3), 2.06(s, 3H, –OAc), 2.24(s, 3H,
21-CH3), 4.64(m, 1H, 3a-H), 5.42(d, 1H, 6-H, J= 5.20),
6.39(brd, 1H, 16-H, J= 2.00), 7.44(t, 1H, ph-H, J= 7.88),
7.58(d, 1H, ph-H, J= 7.90), 7.98(d, 1H, ph-H, J= 7.80),
8.05(s, 1H, ph-H).
13
CNMR (125 MHz, CDCl3), d (ppm):
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46.99, 38.17, 36.87, 36.81, 35.32, 32.18, 31.57, 30.31, 27.75,
21.43, 20.86, 19.22, 15.82, 13.55. ESI-MS m/z [M+Na]+:
531.88.
2.2.8. 3b-(Acetyloxy)pregna-5,16-dien-20-one O-(2,4-
dichlorobenzoyl) oxime (3h): mp. 156–158 C
IR: 2900, 1729, 1373, 1263, 1244, 1097, 1034, 910, 839, 787,
761, 675 cm1.
1
HNMR (500 MHz, CDCl3), d (ppm): 1.04(s,
3H, 18-CH3), 1.08(s, 3H, 19-CH3), 2.07(s, 3H, –OAc), 2.20(s,
3H, 21-CH3), 4.61(m, 1H, 3a-H), 5.41(d, 1H, 6-H, J= 5.20),
6.36(brd, 1H, 16-H, J= 2.00), 7.36(dd, 1H, ph-H, J= 2.00,
8.40), 7.52(d, 1H, ph-H, J= 2.00), 7.83(d, 1H, ph-H,
J= 8.40).
13
CNMR (125 MHz, CDCl3), d (ppm): 170.54,
162.75, 160.49, 150.77, 140.31, 138.29, 138.14, 134.54, 132.38,
130.90, 128.34, 127.14, 122.07, 73.93, 56.92, 50.36, 46.93,
38.17, 36.87, 36.79, 35.25, 32.18, 31.56, 30.29, 27.75, 21.43,
20.81, 19.21, 15.77, 13.91. ESI-MS m/z [M+Na]+: 565.73.2.2.9. 3b-(Acetyloxy)pregna-5,16-dien-20-one O-(3,4-
dichlorobenzoyl) oxime (3i): mp. 186–188 C
IR: 2900, 1749, 1723, 1250, 1229, 1087, 1032, 919, 862, 749,
675 cm1.
1
HNMR (500 MHz, CDCl3), d (ppm): 1.07(s, 3H,
18-CH3), 1.09(s, 3H, 19-CH3), 2.06(s, 3H, –OAc), 2.23(s, 3H,
21-CH3), 4.65(m, 1H, 3a-H), 5.44(d, 1H, 6-H, J= 5.20),
6.39(brd, 1H, 16-H, J= 2.00), 7.58(d, 1H, ph-H,
J= 8.35), 7.92(dd, 1H, ph-H, J= 1.95, 8.30), 8.15(d, 1H,
ph-H, J= 1.90).
13
CNMR (125 MHz, CDCl3), d (ppm):
170.52, 161.90, 160.77, 150.82, 140.32, 138.18, 137.79,
133.12, 131.34, 130.73, 129.42, 128.60, 122.06, 73.93, 56.94,
50.38, 46.99, 38.17, 36.88, 36.81, 35.31, 32.19, 31.56, 30.30,
27.75, 21.43, 20.86, 19.21, 15.81, 13.56. ESI-MS m/z
[M+Na]+: 566.99.
2.2.10. 3b-(Acetyloxy)pregna-5,16-dien-20-one O-(3,5-
dichlorobenzoyl) oxime (3j): mp. 183–185 C
IR: 2900, 1752, 1725, 1250, 1122, 1088, 1032, 894, 865, 802,
752, 659 cm1.
1
HNMR (500 MHz, CDCl3), d (ppm): 1.07(s,
3H, 18-CH3), 1.09(s, 3H, 19-CH3), 2.06(s, 3H, –OAc), 2.24(s,
3H, 21-CH3), 4.64(m, 1H, 3a-H), 5.42(d, 1H, 6-H, J= 5.20),
6.40(brd, 1H, 16-H, J= 2.00), 7.59(s, 1H, ph-H), 7.93(s, 1H,
ph-H), 7.94(s, 1H, ph-H).
13
CNMR (125 MHz, CDCl3), d
(ppm): 170.52, 161.44, 160.97, 150.74, 140.32, 138.37, 135.45,
132.95, 132.44, 127.88, 122.06, 73.93, 56.93, 50.37, 46.99,
38.17, 36.88, 36.81, 35.29, 32.20, 31.56, 30.30, 27.75, 21.43,
20.86, 19.22, 15.80, 13.62. ESI-MS m/z [M+Na]+: 565.78.2.2.11. 3b-(Acetyloxy)pregna-5,16-dien-20-one O-(2-
bromobenzoyl) oxime (3k): mp. 162–164 C
IR: 2900, 1760, 1726, 1235, 1088, 1028, 908, 834, 741 cm1.
1
HNMR (500 MHz, CDCl3), d (ppm): 1.04(s, 3H, 18-CH3),
1.08(s, 3H, 19-CH3), 2.06(s, 3H, –OAc), 2.21(s, 3H, 21-CH3),
4.61(m, 1H, 3a-H), 5.41(d, 1H, 6-H, J= 5.20), 6.36(brd, 1H,
16-H, J= 2.00), 7.34(td, 1H, ph-H, J= 1.80, 7.65), 7.39(td,
1H, ph-H, J= 1.20, 7.50), 7.67(dd, 1H, ph-H, J= 1.10,
7.85), 7.78(dd, 1H, ph-H, J= 1.78, 7.63).
13
CNMR
(125 MHz, CDCl3), d (ppm): 170.54, 164.21, 160.29, 150.89,
140.31, 137.85, 134.12, 132.37, 131.08, 127.18, 122.09, 121.34,
73.95, 56.93, 50.37, 46.92, 38.17, 36.87, 36.80, 35.21, 32.15,steroidal C-20 oxime ester derivatives from 16-DPA. Arabian Journal of Chem-
4 J.-J. Tang et al.31.56, 30.29, 27.75, 21.43, 20.80, 19.21, 15.77, 13.83. ESI-MS
m/z [M+Na]+: 575.74.
2.2.12. 3b-(Acetyloxy)pregna-5,16-dien-20-one O-(3-
bromobenzoyl) oxime (3l): mp. 158–160 C
IR: 2900, 1751, 1728, 1232, 1061, 1030, 916, 845, 745, 733,
693 cm1.
1
HNMR (500 MHz, CDCl3), d (ppm): 1.08(s, 3H,
18-CH3), 1.09(s, 3H, 19-CH3), 2.06(s, 3H, –OAc), 2.24(s, 3H,
21-CH3), 4.64(m, 1H, 3a-H), 5.41(d, 1H, 6-H, J= 5.20),
6.39(brd, 1H, 16-H, J= 2.00), 7.37(t, 1H, ph-H, J= 7.88),
7.73(d, 1H, ph-H, J= 7.70), 8.03(d, 1H, ph-H, J= 7.80),
8.21(s, 1H, ph-H).
13
CNMR (125 MHz, CDCl3), d (ppm):
170.52, 162.41, 160.64, 150.92, 140.32, 137.95, 136.05, 132.43,
131.54, 130.11, 128.15, 122.58, 122.08, 73.94, 56.94, 50.39,
46.99, 38.17, 36.88, 36.81, 35.31, 32.18, 31.57, 30.31, 27.75,
21.43, 20.86, 19.22, 15.82, 13.56. ESI-MS m/z [M+Na]+:
575.77.2.2.13. 3b-(Acetyloxy)pregna-5,16-dien-20-one O-(4-
bromobenzoyl) oxime (3m): mp. 157–159 C
IR: 2900, 1742, 1591, 1240, 1072, 1031, 1010, 904, 848, 750,
679 cm1.
1
HNMR (500 MHz, CDCl3), d (ppm): 1.08(s, 3H,
18-CH3), 1.09(s, 3H, 19-CH3), 2.08(s, 3H, –OAc), 2.23(s, 3H,
21-CH3), 4.64(m, 1H, 3a-H), 5.41(d, 1H, 6-H, J= 5.20),
6.38(brd, 1H, 16-H, J= 2.00), 7.62(s, 1H, ph-H), 7.64(s, 1H,
ph-H), 7.94(s, 1H, ph-H), 7.96(s, 1H, ph-H).
13
CNMR
(125 MHz, CDCl3), d (ppm): 170.53, 163.03, 160.46, 150.97,
140.32, 137.84, 131.90, 131.01, 128.46, 128.22, 122.08, 73.94,
56.94, 50.38, 46.99, 38.17, 36.87, 36.81, 35.33, 32.17, 31.57,
30.31, 27.75, 21.43, 20.86, 19.21, 15.82, 13.50. ESI-MS m/z
[M+Na]+: 575.84.2.2.14. 3b-(Acetyloxy)pregna-5,16-dien-20-one O-(2-
iodobenzoyl) oxime (3n): mp. 130–132 C
IR: 2900, 1729, 1372, 1235, 1074, 1032, 1012, 907, 835,
739 cm1.
1
HNMR (500 MHz, CDCl3), d (ppm): 1.04(s, 3H,
18-CH3), 1.08(s, 3H, 19-CH3), 2.06(s, 3H, –OAc), 2.21(s, 3H,
21-CH3), 4.63(m, 1H, 3a-H), 5.41(d, 1H, 6-H, J= 5.20),
6.36(brd, 1H, 16-H, J= 2.00), 7.19(td, 1H, ph-H, J= 1.50,
7.70), 7.44(t, 1H, ph-H, J= 7.55), 7.78(dd, 1H, ph-H,
J= 1.50, 7.75), 8.01(d, 1H, ph-H, J= 7.90).
13
CNMR
(125 MHz, CDCl3), d (ppm): 170.54, 164.54, 160.29, 150.90,
141.05, 140.31, 137.83, 135.55, 132.42, 130.62, 127.88, 122.09,
93.84, 73.95, 56.94, 50.37, 46.93, 38.17, 36.87, 36.80, 35.21,
32.15, 31.57, 30.30, 27.75, 21.44, 20.82, 19.22, 15.80, 13.82.
ESI-MS m/z [M+Na]+: 623.69.2.2.15. 3b-(Acetyloxy)pregna-5,16-dien-20-one O-(3-
methoxybenzoyl) oxime (3o): mp. 184–186 C
IR: 2900, 1744, 1728, 1270, 1245, 1215, 1084, 1031, 900, 882,
746 cm1.
1
HNMR (500 MHz, CDCl3), d (ppm): 1.08(s, 3H,
18-CH3), 1.09(s, 3H, 19-CH3), 2.06(s, 3H, –OAc), 2.23(s, 3H,
21-CH3), 3.88(s, 3H, ph-OCH3), 4.63(m, 1H, 3a-H), 5.41(d,
1H, 6-H, J= 5.20), 6.36(brd, 1H, 16-H, J= 2.00), 7.14(d,
1H, ph-H, J= 8.20), 7.39(t, 1H, ph-H, J= 7.95), 7.62(s,
1H, ph-H), 7.68(d, 1H, ph-H, J= 7.60).
13
CNMR (125 MHz,
CDCl3), d (ppm): 170.53, 163.62, 160.27, 159.63, 151.09,
140.32, 137.53, 130.83, 129.52, 122.10, 121.83, 119.31, 114.37,
73.95, 56.95, 55.43, 50.39, 46.99, 38.17, 36.87, 36.81, 35.34,Please cite this article in press as: Tang, J.-J. et al., Synthesis and cytotoxicity of nove
istry (2015), http://dx.doi.org/10.1016/j.arabjc.2014.12.03232.15, 31.58, 30.31, 27.75, 21.43, 20.86, 19.22, 15.82, 13.48.
ESI-MS m/z [M+Na]+: 527.98.2.2.16. 3b-(Acetyloxy)pregna-5,16-dien-20-one O-(4-
methoxybenzoyl) oxime (3p): mp. 165–167 C
IR: 2900, 1742, 1725, 1604, 1255, 1178, 1072, 1039, 911, 854,
762, 692, 615 cm1.
1
HNMR (500 MHz, CDCl3), d (ppm):
1.08(s, 3H, 18-CH3), 1.09(s, 3H, 19-CH3), 2.06(s, 3H, –OAc),
2.23(s, 3H, 21-CH3), 3.88(s, 3H, ph-OCH3), 4.63(m, 1H, 3a-
H), 5.41(d, 1H, 6-H, J= 5.20), 6.36(brd, 1H, 16-H,
J= 2.00), 6.97(s, 1H, ph-H), 6.96(s, 1H, ph-H), 8.05(s, 1H,
ph-H), 8.07(s, 1H, ph-H).
13
CNMR (125 MHz, CDCl3), d
(ppm): 170.52, 163.50, 159.85, 151.23, 140.33, 137.15, 132.83,
131.58, 122.10, 121.82, 114.15, 113.80, 73.96, 56.96, 55.44,
50.40, 46.99, 38.18, 36.82, 35.35, 32.13, 31.59, 30.32, 27.75,
21.43, 20.86, 19.21, 15.83, 13.42. ESI-MS m/z [M+Na]+:
528.02.2.2.17. 3b-(Acetyloxy)pregna-5,16-dien-20-one O-(3,4-
dimethoxybenzoyl) oxime (3q): mp. 166–168 C
IR: 2900, 1724, 1269, 1246, 1212, 1172, 1141, 1082, 1029, 903,
886, 754 cm1.
1
HNMR (500 MHz, CDCl3), d (ppm): 1.08(s,
3H, 18-CH3), 1.09(s, 3H, 19-CH3), 2.06(s, 3H, –OAc), 2.23(s,
3H, 21-CH3), 3.88(s, 3H, ph-OCH3), 3.89(s, 3H, ph-OCH3),
4.63(m, 1H, 3a-H), 5.41(d, 1H, 6-H, J= 5.20), 6.36(brd, 1H,
16-H, J= 2.00), 6.93(d, 1H, ph-H, J= 8.50), 7.61(d, 1H,
ph-H, J= 1.80), 7.73(dd, 1H, ph-H, J= 1.88, 8.43).
13
CNMR
(125 MHz, CDCl3), d (ppm): 170.53, 163.60, 159.99, 153.18,
151.18, 148.81, 140.32, 137.25, 123.43, 122.09, 121.92, 112.14,
110.40, 73.95, 56.96, 56.04, 56.00, 50.40, 47.00, 38.17, 36.87,
36.81, 35.35, 32.14, 31.58, 30.32, 27.75, 21.43, 20.86, 19.21,
15.82, 13.42. ESI-MS m/z [M+Na]+: 557.96.2.2.18. 3b-(Acetyloxy)pregna-5,16-dien-20-one O-acetyl oxime
(3r): mp. 163–165 C
IR: 2933, 1763, 1724, 1368, 1249, 1138, 1074, 1032, 958, 895,
867 cm1.
1
HNMR (500 MHz, CDCl3), d (ppm): 1.02(s, 3H,
18-CH3), 1.08(s, 3H, 19-CH3), 1.23(t, 3H, 24-CH3, J= 7.50),
2.05(s, 3H, –OAc), 2.10(s, 3H, 21-CH3), 4.63(m, 1H, 3a-H),
5.41(d, 1H, 6-H, J= 5.20), 6.31(brd, 1H, 16-H, J= 2.00).
13
CNMR (125 MHz, CDCl3), d (ppm): 172.96, 170.55,
159.02, 150.97, 140.25, 137.24, 122.11, 73.92, 56.90, 50.35,
46.85, 38.15, 36.87, 36.79, 35.34, 32.04, 31.54, 30.27, 27.74,
26.56, 21.43, 20.86, 19.21, 15.82, 13.22, 8.97. ESI-MS m/z
[M+Na]+: 450.05.2.2.19. 3b-(Acetyloxy)pregna-5,16-dien-20-one O-propionyl
oxime (3s): mp. 163–164 C
IR: 2933, 1755, 1724, 1370, 1251, 1161, 1031, 958, 904,
803 cm1.
1
HNMR (500 MHz, CDCl3), d (ppm): 1.00(t, 3H,
25-CH3, J= 7.50), 1.02(s, 3H, 18-CH3), 1.07(s, 3H, 19-CH3),
2.05(s, 3H, –OAc), 2.10(s, 3H, 21-CH3), 4.62(m, 1H, 3a-H),
5.41(d, 1H, 6-H, J= 5.20), 6.30(brd, 1H, 16-H, J= 2.00).
13
CNMR (125 MHz, CDCl3), d (ppm): 171.82, 170.54,
159.08, 151.01, 140.26, 137.19, 122.11, 76.78, 73.93, 56.91,
50.35, 46.85, 38.15, 36.86, 36.79, 35.33, 35.03, 32.04, 31.54,
30.27, 27.74, 21.43, 20.84, 19.21, 18.28, 15.82, 13.77, 13.25.
ESI-MS m/z [M+Na]+: 464.06.l steroidal C-20 oxime ester derivatives from 16-DPA. Arabian Journal of Chem-
Synthesis and cytotoxicity of novel steroidal C-20 oxime ester derivatives from 16-DPA 52.2.20. 3b-(Acetyloxy)pregna-5,16-dien-20-one O-butyryl
oxime (3t): mp. 166–168 C
IR: 2933, 1770, 1722, 1363, 1249, 1138, 1090, 1030, 957, 896,
842 cm1.
1
HNMR (500 MHz, CDCl3), d (ppm): 0.95(t, 3H,
26-CH3, J= 7.50), 1.02(s, 3H, 18-CH3), 1.08(s, 3H, 19-CH3),
2.05(s, 3H, –OAc), 2.10(s, 3H, 21-CH3), 4.62(m, 1H, 3a-H),
5.41(d, 1H, 6-H, J= 5.20), 6.30(brd, 1H, 16-H, J= 2.00).
13
CNMR (125 MHz, CDCl3), d (ppm): 172.00, 170.55,
159.06, 151.01, 140.26, 137.19, 122.11, 73.93, 56.91, 50.35,
46.85, 38.15, 36.86, 36.79, 35.33, 32.86, 32.04, 31.55, 30.27,
27.74, 26.84, 22.32, 21.44, 20.83, 19.21, 15.82, 13.74, 13.25.
ESI-MS m/z [M+Na]+: 478.05.
2.2.21. 3b-(Acetyloxy)pregna-5,16-dien-20-one O-pentanoyl
oxime (3u): mp. 169–171 C
IR: 2934, 1768, 1722, 1365, 1248, 1137, 1094, 1029, 957, 895,
866, 841, 669 cm1.
1
HNMR (500 MHz, CDCl3), d (ppm):
0.92(t, 3H, 27-CH3, J= 7.50), 1.02(s, 3H, 18-CH3), 1.08(s,
3H, 19-CH3), 2.05(s, 3H, –OAc), 2.10(s, 3H, 21-CH3),
4.62(m, 1H, 3a-H), 5.41(d, 1H, 6-H, J= 5.20), 6.30(brd, 1H,
16-H, J= 2.00).
13
CNMR (125 MHz, CDCl3), d (ppm):
172.01, 170.55, 159.06, 151.01, 140.26, 137.18, 122.11, 73.93,
56.91, 50.35, 46.85, 38.15, 36.86, 36.79, 35.33, 33.11, 32.04,
31.55, 31.36, 30.27, 27.74, 24.47, 22.36, 21.44, 20.83, 19.21,
15.82, 13.91, 13.25. ESI-MS m/z [M+Na]+: 492.07.Table 1 Cytotoxic activity of some derivatives against three cancer
No. Structure
3a
3f
3g
3j
3l
Etoposide
a Cells were treated with some derivatives at the concentration of 30 lM
exclusion assay. All data are the average of two determinations. Compoun
Please cite this article in press as: Tang, J.-J. et al., Synthesis and cytotoxicity of novel
istry (2015), http://dx.doi.org/10.1016/j.arabjc.2014.12.0322.2.22. 3b-(Acetyloxy)pregna-5,16-dien-20-one O-hexanoyl
oxime (3v): mp. 170–173 C
IR: 2934, 1768, 1726, 1364, 1255, 1135, 1097, 1030, 896, 866,
844, 671 cm1.
1
HNMR (500 MHz, CDCl3), d (ppm): 0.90(t,
3H, 28-CH3, J= 7.50), 1.02(s, 3H, 18-CH3), 1.08(s, 3H, 19-
CH3), 2.05(s, 3H, –OAc), 2.10(s, 3H, 21-CH3), 4.62(m, 1H,
3a-H), 5.41(d, 1H, 6-H, J= 5.20), 6.30(brd, 1H, 16-H,
J= 2.00).
13
CNMR (125 MHz, CDCl3), d (ppm): 172.03,
170.54, 159.05, 151.01, 140.26, 137.18, 122.11, 73.93, 56.91,
50.35, 46.85, 38.15, 36.86, 36.79, 35.33, 33.16, 32.04, 31.55,
31.50, 30.27, 28.89, 27.74, 24.75, 22.50, 21.43, 20.84, 19.21,
15.82, 14.05, 13.25. ESI-MS m/z [M+Na]+: 506.08.
2.2.23. 3b-(Acetyloxy)pregna-5,16-dien-20-one O-heptanoyl
oxime (3w): mp. 173–174 C
IR: 2933, 1768, 1726, 1363, 1253, 1135, 1098, 1030, 957, 895,
844 cm1.
1
HNMR (500 MHz, CDCl3), d (ppm): 0.89(t, 3H,
29-CH3, J= 7.50), 1.02(s, 3H, 18-CH3), 1.08(s, 3H, 19-CH3),
2.05(s, 3H, –OAc), 2.10(s, 3H, 21-CH3), 4.62(m, 1H, 3a-H),
5.41(d, 1H, 6-H, J= 5.20), 6.30(brd, 1H, 16-H, J= 2.00).
13
CNMR (125 MHz, CDCl3), d (ppm): 172.06, 170.55,
159.04, 151.01, 140.26, 137.18, 122.11, 73.93, 56.90, 50.35,
46.85, 38.15, 36.86, 36.78, 35.33, 33.16, 32.04, 31.67, 31.55,
30.27, 29.18, 28.96, 27.74, 24.79, 22.61, 21.43, 20.84, 19.20,
15.82, 14.07, 13.25. ESI-MS m/z [M+Na]+: 520.08.cell lines NB4, PC-3 and HeLa.
Inhibitory eﬀect (100%)a
NB4 (%) PC-3 (%) HeLa (%)
<20 <20 57.0
<20 <20 55.4
<20 <20 53.9
62.4 50.4 <20
55.4 55.9 <20
99.2 97.8 98.2
for 48 h, and inhibitory effects were measured by trypan blue dye
ds with inhibitory effect < 20% on three cancer cells were not shown.
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6 J.-J. Tang et al.2.3. Cytotoxic activities of compounds on three cancer cell lines
The numbers of viable cells were counted using a trypan blue
dye exclusion test (Schlager and Adams, 1983). The reactivity
of trypan blue is based on the fact that the chromopore is neg-
atively charged and does not interact with the cell unless the
membrane is damaged. Therefore, all the cells which exclude
the dye are viable. In the experiment, NB4, PC-3 and HeLa cells
were seeded at a density of 1 · 105 cells/well in 24 well multi-
well plates and treated with derivatives at the concentration
of 30 lM.After incubation in a humidiﬁed CO2 (5%) incubator
at 37 C for 48 h, cells were harvested and stained with trypan
blue, and then observed with hematocyte counter under micro-
scope for cell number counting. The percentage dead rates of
cells exposed to the derivatives were calculated by assuming
the stained cells of total cells (stained cells + unstained cells)
to be 100%. Etoposide was preferred as the positive control.
3. Results and discussion
16-DPA is a versatile intermediate in the synthesis of steroid
hormones, because it is an ideal platform for preparation of
bioactive drugs. In the previous work, 23 novel steroidal
C-20 oxime ester derivatives were designed and synthesized
from 16-DPA. Firstly, a key intermediate 2, 3b-acetoxy-5,16-
pregnadien-20-oxime, was obtained in excellent yield (95%)
by oximation condensation of 16-DPA and hydroxylamine in
a solution of 95% EtOH and pyridine at 100 C. Secondly,
acylation of 2 with appropriate acid chlorides (aromatic and
aliphatic chains moieties) in the presence of Et3N in dry
CH2Cl2 at room temperature afforded desired C-20 oxime
ester derivatives 3a-w with above 85% yield (Scheme 1). The
structures of the compounds prepared were characterized by
m.p., IR, 1D-NMR and ESI-MS.
All derivatives were tested at the concentration of 30 lM
against NB4, PC-3 and HeLa cells using trypan blue dye exclu-
sion in vitro. Primary cytotoxic activities results were shown in
Table 1 and inhibitory effect < 20% on three cancer cells was
not shown. Of all the compounds containing these derivatives
and their precursors, ﬁve compounds (3a, 3f, 3g, 3j and 3l)
exhibited potent cytotoxic activities. Derivatives 3a, 3f and
3g showed an inhibition activity against HeLa cells with inhi-
bition rates above 50%, while were inactive on other two cell
lines NB4 and PC-3 (inhibition effect < 20%). In contrast,
3j and 3l showed potent cytotoxic activities against NB4 and
PC-3 cells, and no cytotoxic activity against HeLa cells. This
indicated that the type and position of the substituted group
introduced to the benzene ring could obviously affect their
bioactivity.
When oxime ester derivatives (3r-w) were acylated substitu-
tion with aliphatic chain, the cytotoxicity nearly loosed against
these cell lines, and when ﬂuoro or chloro was introduced to
the ortho- or meta-position of benzoyl, the activities were much
higher than corresponding bromo- and iodo-derivatives.
Moreover, the cytotoxicity response may be sensitive to a vari-
ety of functional groups and positions on the benzene ring.
4. Conclusion
A series of new steroidal C-20 oxime ester derivatives were
prepared and their cytotoxic activities against three humanPlease cite this article in press as: Tang, J.-J. et al., Synthesis and cytotoxicity of nove
istry (2015), http://dx.doi.org/10.1016/j.arabjc.2014.12.032cancer cells NB4, PC-3 and HeLa were evaluated. Although
some derivatives exhibited certain cytotoxic activity, there is
no obvious structure–activity relationship tendency in gen-
eral. Indeed, the experiment mentioned above is only a pre-
liminary investigation, and there are more works to be
carried out, and biological activities in detail deserve further
investigation.Acknowledgment
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